Cite
HARVARD Citation
Dean, R. et al. (n.d.). P1–342: Effects of solanezumab versus placebo administration on biomarkers in people with mild‐to‐moderate Alzheimer's disease: Results from two phase III clinical trials. Alzheimer's & dementia. p. P283. [Online].